Profile data is unavailable for this security.
About the company
LivaNova PLC is a medical device company. The Company is focused on the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems throughout the world. The Company operates through two segments: Cardiac Surgery and Neuromodulation. Its Cardiac Surgery Business Franchise (CS) is engaged in the development, production and sale of cardiac surgery products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and other accessories used for extracorporeal circulation, systems for autologous blood transfusion and blood washing. Its Neuromodulation Business Franchise designs develops and markets neuromodulation-based medical devices for the treatment of epilepsy and difficult-to-treat depression (DTD) and obstructive sleep apnea.
- Revenue in USD (TTM)1.02bn
- Net income in USD-379.12m
- Incorporated2015
- Employees4.00k
- LocationLivaNova PLC20 Eastbourne TerraceLONDON W2 6LGUnited KingdomGBR
- Phone+44 203 325 0662
- Websitehttp://www.livanova.com/home.action
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Integer Holdings Corp | 1.11bn | 96.72m | 3.03bn | 7.50k | 31.53 | 2.31 | 17.11 | 2.74 | 2.92 | 2.92 | 33.39 | 39.84 | 0.4536 | 5.01 | 5.30 | 147,652.10 | 3.96 | 2.29 | 4.24 | 2.47 | 27.49 | 29.44 | 8.73 | 5.19 | 1.75 | 3.73 | 0.3372 | 0.00 | -14.68 | 6.05 | -15.30 | -- | 2.89 | -- |
| Axonics Inc | 150.27m | -68.17m | 3.10bn | 416.00 | -- | 6.14 | -- | 20.62 | -1.68 | -1.68 | 3.75 | 10.94 | 0.3287 | 1.14 | 7.56 | 361,221.20 | -14.91 | -- | -15.87 | -- | 61.94 | -- | -45.36 | -- | 10.73 | -7.31 | 0.0002 | -- | 707.06 | -- | 31.30 | -- | -- | -- |
| Patterson Companies, Inc. | 6.28bn | 165.57m | 3.11bn | 7.80k | 18.77 | 3.18 | 12.73 | 0.4952 | 1.70 | 1.70 | 64.56 | 10.07 | 2.33 | 6.87 | 16.84 | 805,269.90 | 6.10 | -0.3475 | 9.84 | -0.492 | 19.54 | 21.73 | 2.62 | -0.1996 | 0.7877 | -- | 0.3914 | -- | 7.69 | 1.88 | 126.51 | -3.43 | -20.13 | 2.93 |
| Cytek Biosciences Inc | -100.00bn | -100.00bn | 3.20bn | 429.00 | -- | -- | -- | -- | -- | -- | -- | 1.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 6.76 | -- | 0.00 | -- | 60.39 | -- | 119.11 | -- | -- | -- |
| AtriCure Inc. | 243.13m | -56.68m | 3.32bn | 750.00 | -- | 8.62 | -- | 13.65 | -1.29 | -1.29 | 5.53 | 8.39 | 0.346 | 1.75 | 8.57 | 324,177.30 | -8.07 | -8.44 | -8.72 | -9.35 | 74.60 | 72.67 | -23.31 | -17.00 | 2.94 | -11.74 | 0.1251 | -- | -10.52 | 9.74 | -36.83 | -- | -17.12 | -- |
| Adapthealth Corp | 1.75bn | -90.37m | 3.38bn | 8.70k | -- | 1.78 | 101.66 | 1.93 | -1.97 | -1.97 | 18.82 | 14.53 | 0.6435 | 26.24 | 8.29 | 200,718.00 | -4.61 | -- | -5.47 | -- | 20.40 | -- | -7.16 | -- | 0.8407 | 1.19 | 0.5004 | -- | 102.15 | -- | -657.38 | -- | -- | -- |
| Haemonetics Corporation | 903.41m | 64.49m | 3.66bn | 2.71k | 56.96 | 5.40 | 23.88 | 4.05 | 1.26 | 1.26 | 17.69 | 13.27 | 0.5599 | 1.56 | 6.59 | 333,609.30 | 4.00 | 3.92 | 4.98 | 4.91 | 46.27 | 46.02 | 7.14 | 5.59 | 1.57 | 6.20 | 0.5367 | 0.00 | -11.94 | -0.859 | 3.85 | -- | -18.40 | -- |
| Merit Medical Systems, Inc. | 1.03bn | 28.24m | 3.98bn | 5.99k | 141.40 | 4.01 | 33.85 | 3.86 | 0.5006 | 0.5006 | 18.31 | 17.65 | 0.6141 | 2.80 | 7.06 | 172,185.20 | 1.68 | 1.36 | 1.90 | 1.52 | 43.56 | 43.60 | 2.74 | 2.17 | 1.21 | 12.00 | 0.2276 | 0.00 | -3.11 | 12.20 | -280.57 | -- | -1.41 | -- |
| Nevro Corp | 409.13m | -68.27m | 4.19bn | 843.00 | -- | 11.70 | -- | 10.25 | -1.97 | -1.97 | 11.83 | 10.28 | 0.6049 | 1.38 | 6.71 | 485,327.40 | -10.09 | -12.91 | -12.90 | -15.32 | 70.00 | 69.17 | -16.69 | -17.96 | 6.37 | -1.60 | 0.2901 | -- | -7.23 | 39.07 | 19.89 | -- | 3.77 | -- |
| Conmed Corp | 978.50m | 54.14m | 4.23bn | 3.40k | 83.80 | 5.68 | 33.52 | 4.32 | 1.73 | 1.73 | 31.79 | 25.53 | 0.5614 | 2.26 | 6.26 | 287,794.40 | 3.11 | 1.60 | 3.45 | 1.79 | 55.29 | 54.66 | 5.53 | 2.75 | 1.17 | 2.40 | 0.495 | 96.80 | -9.70 | 3.70 | -66.75 | -20.78 | -2.81 | 0.00 |
| LivaNova PLC | 1.02bn | -379.12m | 4.34bn | 4.00k | -- | 3.84 | -- | 4.25 | -7.79 | -7.80 | 20.97 | 21.24 | 0.4171 | 2.33 | 5.55 | 255,431.00 | -15.47 | -4.59 | -19.29 | -5.53 | 65.30 | 64.85 | -37.09 | -11.05 | 0.9711 | -0.6777 | 0.3892 | -- | -13.83 | -- | -120.85 | -- | -- | -- |
| Inari Medical Inc | 208.18m | 25.02m | 4.44bn | 456.00 | 198.30 | 19.97 | 162.71 | 21.33 | 0.4484 | 0.4484 | 3.73 | 4.45 | 0.8712 | 1.38 | 8.88 | 456,526.30 | 10.47 | -- | 11.49 | -- | 92.15 | -- | 12.02 | -- | 6.65 | 298.98 | 0.00 | -- | 173.17 | -- | 1,256.96 | -- | -- | -- |
| Premier Inc | 1.72bn | 260.84m | 4.87bn | 2.60k | 16.68 | 2.18 | 11.45 | 2.83 | 2.38 | 2.38 | 14.64 | 18.20 | 0.5319 | 7.15 | 4.53 | 661,981.60 | 9.41 | 15.80 | 11.58 | 19.54 | 48.65 | 64.20 | 17.70 | 31.72 | 0.8453 | 15.07 | 0.1767 | 5.99 | 32.44 | 8.16 | -56.39 | -20.44 | 2.91 | -- |
| ICU Medical Inc | 1.28bn | 103.26m | 4.89bn | 7.90k | 48.35 | 3.14 | 25.62 | 3.82 | 4.77 | 4.77 | 59.04 | 73.43 | 0.6984 | 2.60 | 8.03 | 161,866.00 | 5.64 | 5.28 | 6.62 | 6.07 | 36.76 | 37.99 | 8.07 | 6.28 | 3.67 | 1,172.47 | 0.0019 | 0.00 | 0.3788 | 30.05 | -14.02 | 14.07 | 48.43 | -- |
| Pacific Biosciences of California Inc | 105.83m | -77.21m | 5.09bn | 412.00 | -- | 19.70 | -- | 48.10 | -0.4648 | -0.4648 | 0.5389 | 1.30 | 0.145 | 3.49 | 6.77 | 256,856.80 | -10.58 | -37.11 | -12.03 | -46.53 | 42.71 | 39.54 | -72.96 | -74.86 | 25.78 | -22.21 | 0.7762 | -- | -13.20 | -3.19 | 134.95 | -- | -19.16 | -- |
| Helen of Troy Limited | 2.16bn | 214.61m | 5.50bn | 1.77k | 26.31 | 4.33 | 21.87 | 2.54 | 8.66 | 8.66 | 87.50 | 52.60 | 0.946 | 2.54 | 5.21 | 1,223,043.00 | 9.38 | 9.55 | 12.36 | 11.73 | 43.86 | 42.29 | 9.92 | 10.48 | 0.8082 | 22.99 | 0.2714 | -- | 22.92 | 8.55 | 58.79 | 21.34 | 42.70 | -- |
Data as of Oct 21 2021. Currency figures normalised to LivaNova PLC's reporting currency: US Dollar USD
44.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Jun 2021 | 5.11m | 9.61% |
| PRIMECAP Management Co.as of 30 Jun 2021 | 4.02m | 7.56% |
| Harris Associates LPas of 30 Jun 2021 | 3.79m | 7.12% |
| Barrow, Hanley, Mewhinney & Strauss LLCas of 30 Jun 2021 | 2.22m | 4.17% |
| SSgA Funds Management, Inc.as of 30 Jun 2021 | 1.97m | 3.71% |
| Eminence Capital LPas of 30 Jun 2021 | 1.65m | 3.11% |
| Hawk Ridge Capital Management LPas of 30 Jun 2021 | 1.30m | 2.44% |
| Paradice Investment Management LLCas of 30 Jun 2021 | 1.19m | 2.23% |
| Bestinver Gesti�n SA SGIICas of 30 Jun 2021 | 1.16m | 2.19% |
| Maverick Capital Ltd.as of 30 Jun 2021 | 1.15m | 2.16% |
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
